The pharmacodynamics and pharmacokinetics of mivacurium in children

Acta Anaesthesiologica Scandinavica

Volumn 46, Issue 5, 2002, Pages 512-518

  Østergaard, Doris ^a   Gatke M R ^a   Berg, H ^a   Rasmussen, S N ^a   Viby Mogensen, J ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Butyrylcholinesterase; Children; Cholinesterase; Mivacurium; Neuromuscular relaxants; Pharmacodynamics; Pharmacokinetics; Pseudocholinesterase

Indexed keywords

CHOLINESTERASE; DIAZEPAM; DRUG METABOLITE; FENTANYL; HALOTHANE; MIVACURIUM; NITROUS OXIDE; THIOPENTAL;

ADOLESCENT; ANESTHESIA INDUCTION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME ACTIVITY; FEMALE; HUMAN; ISOMER; MALE; MYOGRAPHY; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; PHENOTYPE; PREMEDICATION; PRIORITY JOURNAL; STEADY STATE; THUMB;

ADOLESCENT; ALGORITHMS; ANESTHESIA, INHALATION; AREA UNDER CURVE; CHILD; CHILD, PRESCHOOL; CHOLINESTERASES; ELECTRIC STIMULATION; FEMALE; HALF-LIFE; HUMANS; ISOQUINOLINES; MALE; MONITORING, INTRAOPERATIVE; MYOGRAPHY; NEUROMUSCULAR NONDEPOLARIZING AGENTS; STEREOISOMERISM;

EID: 0036112576     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-6576.2002.460507.x     Document Type: Article

References (24)

1. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U)
2. Clinical pharmacology of mivacurium chloride (BW 1090U) in children during nitrous oxide-halothane and nitrous oxide narcotic anesthesia
3. Neuromuscular and cardiovascular effects of mivacurium in children
4. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia
5. Neuromuscular blocking agents in paediatric anaesthesia
6. Pseudocholinesterase activity and duration of mivacurium-induced neuromuscular blockade in children
7. Cholinesterase- und transaminasen-aktivität im serum von kindern (3 bis 6 jahre alt)
8. Discrimination of phenotypes in human serum cholinesterase deficiency
9. Identification of human plasma cholinesterase variants in 6.688 individuals using biochemical analysis
10. The pharmacokinetics and steady state pharmacodynamics of mivacurium in children
11. Decreased mivacurium requirements and delayed neuromuscular recovery during sevoflurane anesthesia in children and adults
12. Does age or pseudocholinesterase activity predict mivacurium infusion rate in children?
13. Pharmacokinetics and pharmacodynamics of mivacurium in anaesthetized paediatric patients undergoing elective surgery
14. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents
15. Stereo-selective high-performance liquid chromatographic assay with fluorometric detection for the isomers of mivacurium in human plasma
16. Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury
17. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium
18. Mivacurium induced neuromuscular blockade during sevoflurane and halothane anaesthesia in children
19. Dose-response and minimum time to satisfactory intubation conditions after mivacurium in children
20. Neuromuscular blocking agents in paediatric patients: Influence of age on the response
21. Importance of early bloodsampling on vecuronium pharmacokinetic and pharmacodynamic parameters
22. Pharmacokinetics of mivacurium isomers and their metabolites in healthy volunteers after intravenous bolus administration